Toggle light / dark theme

The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever

Dr. Norman Lepor, MD — Founder and Director of the National Heart Institute, Clinical Professor of Medicine at UCLA, and Attending Cardiologist at Cedars-Sinai.


Heart disease remains the leading cause of death worldwide, and one of its most important modifiable risk factors is elevated LDL cholesterol — the so-called \.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */